REGENERX BIOPHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2022.
  • Regenerx Biopharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $86.3K, a 1.47% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $511K, a 20.5% increase year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $512K, a 28.7% increase from 2021.
  • Regenerx Biopharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $398K, a 19.8% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2020 was $332K, a 23.1% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $512K +$114K +28.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-11
2021 $398K +$65.8K +19.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-11
2020 $332K +$62.3K +23.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $270K -$6.39K -2.31% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $276K +$4.75K +1.75% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $271K -$71.1K -20.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $342K +$111K +47.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 $232K +$68.2K +41.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-29
2014 $163K +$90.2K +123% Jan 1, 2014 Dec 31, 2014 10-K 2016-04-11
2013 $73.2K -$95.3K -56.5% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $168K -$53.3K -24% Jan 1, 2012 Dec 31, 2012 10-K 2014-04-04
2011 $222K Jan 1, 2011 Dec 31, 2011 10-K 2013-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.